Ipratropium bromide

🧮 Dose calculator

Chronic obstructive pulmonary disease (COPD) · Regimen source: FDA Atrovent HFA · 2

• • Extra inhalations as required; total no more than 12 in 24 h. No shaking needed. FDA Atrovent HFA · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyNo specific problem stated

  Label: minimal systemic absorption; fetal exposure not expected. FDA Atrovent HFA · 8.1

  “Risk Summary Ipratropium is negligibly absorbed systemically following oral inhalation; therefore, maternal use is not expected to result in fetal exposure to the drug [ see Clinical Pharmacology (12.3) ].”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Atrovent HFA · 8.2

  “Risk Summary There are no data on the presence of ipratropium in either human or animal milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Atrovent HFA · 8.4

  “Safety and effectiveness in the pediatric population have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Atrovent HFA · 8.5

  “No overall differences in safety or effectiveness were observed between these subjects and younger subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.